Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1963161
PUBLISHER: BCC Research | PRODUCT CODE: 1963161
Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets
PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for cloud computing in cell biology, genomics and drug development is estimated to grow from $7.2 billion in 2025 to $15.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.7% from 2025 through 2030.
The North American market for cloud computing in cell biology, genomics and drug development is estimated to grow from $3.2 billion in 2025 to $7 billion by the end of 2030, at a CAGR of 16.9% from 2025 through 2030.
The Asia-Pacific market for cloud computing in cell biology, genomics and drug development is estimated to grow from $1.6 billion in 2025 to $3.8 billion by the end of 2030, at a CAGR of 18.7% from 2025 through 2030.
Report Scope
The report provides an overview of global cloud computing in cell biology, genomics and drug development, and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on branch of biology, deployment type, application, end user and region. Based on the branch of biology, the market is further segmented into human biology, microbiology, animal biology and plant biology. The market is categorized by deployment type into public cloud, private cloud and hybrid cloud. By application, the market is segmented as discovery and preclinical research, clinical trials, pharma manufacturing, plant and microbial gene analysis, and commercialization. The market is categorized based on end user into pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations (CROs), and others (such as academia, government or agritech). The study covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in each region.
The report also sheds light on developments related to venture capital (VC) and corporate investments, regulatory trends, and enterprise strategies of key firms as well as potential future opportunities stemming from cloud computing in cell biology, genomics, drug development of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis, and tariff assessments makes this report a critical resource for stakeholders, investors, and policymakers seeking to understand and capitalize on the rapidly developing field of cloud computing in cell biology, genomics and drug development. The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings of key companies in the cloud computing in cell biology, genomics and drug development market. It also has a dedicated section of company profiles that covers details of leading key market participants.
Report Includes
- 52 data tables and 51 additional tables
- An analysis of the global market for cloud computing applications in cell biology, genomics and drug development
- Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the market size and revenue growth prospects, along with a market share analysis by the branch of biology, deployment type, application, end user and region
- Facts and figures about market dynamics, opportunities and deterrents, technological advances, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter's Five Forces model, as well as global supply chain analyses
- Information about key partnerships between cloud service providers and pharma/biotech companies and investment in the pharmaceutical R&D sector
- A relevant patent analysis, featuring key granted and published patents
- Analysis of the industry structure, including companies' market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Profiles of the leading companies, including Alphabet Inc. (Google), Amazon Web Services (AWS) Inc., IBM Corp., Microsoft and Oracle Corp.
Product Code: BIO200B
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Technological Advances
- Market Dynamics and Growth Factors
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Overview and Market Definition
- Leveraging Cloud Computing for Collaboration
- Interactions Between Scalability and Collaboration
- Real-Time Applications of Cloud Computing to Achieve Scalability and Collaboration
- Porter's Five Forces Model
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Competition in the Industry
- Threat of Substitutes
- Macroeconomic Factors Analysis
- Growth of Biomedical R&D Budgets and Digital Transformation Budgets
- Rise of Precision Medicine and Data-Heavy Therapeutics
- Scaling Telehealth, Remote Studies and Decentralized Research Models
- Impact of the U.S. Tariffs
- Overview
- Direct Impact: Increased Operational Costs and R&D Expenditure
- Strategic and Operational Impacts
- Asymmetric Impact: Widening the Gap Between "Haves" and "Have-Nots"
- Geopolitical and Long-Term Strategic Shifts
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Explosion of Biological Data - Driving Demand for Scalable Compute and Storage
- Rising Adoption of AI and Advanced Analytics in Biology Demands High-Performance Cloud Infrastructure
- Increasing Demand for Real-Time, Decentralized Collaboration in Pharmaceutical R&D
- Emergence of Cloud-Native Bioinformatics and Lab Informatics Vendors (SaaS Economics)
- Market Restraints
- Data Security and Privacy
- High Costs Associated with Cloud Implementation
- Market Opportunities
- Integration with Real-World Evidence and Clinical Data
- Commercialization of Cloud-Native Bioinformatics as a Service
Chapter 4 Regulatory Landscape
- Overview
- The United States (U.S.)
- European Union (EU)
- Japan
- China
- India
Chapter 5 Emerging Technologies and Developments
- Overview
- Cloud-Native Bioinformatics and Multiomics Integration
- Federated Cloud and Secure Data Sharing
- Digital Twins and Synthetic Data in Drug Development
- High-Performance Computing (HPC) in the Cloud for Genomics and Biology
- AI-Enabled Cloud Manufacturing and Real-World Evidence (RWE)
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis, by Branch of Biology
- Human Biology
- Microbiology
- Animal Biology
- Plant Biology
- Market Analysis, by Deployment Type
- Public Cloud
- Private Cloud
- Hybrid Cloud
- Market Analysis, by Application
- Discovery and Preclinical Research
- Clinical Trials
- Pharma Manufacturing
- Plant and Microbial Gene Analysis
- Commercialization
- Market Analysis, by End User
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- Contract Research Organizations (CROs)
- Others (Academia/Govt./Agritech, etc.)
- Geographic Breakdown
- Market Analysis, by Region
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Patent Review/New Developments
- Key Takeaways
Chapter 8 Competitive Landscape
- Overview
- Key Takeaways
- Cloud Computing Market for Cell Biology, Genomics and Drug Development - Major Companies
Chapter 9 Appendix
- Methodology
- References
- Abbreviations
- Company Profiles
- ALPHABET INC. (GOOGLE INC.)
- AMAZON WEB SERVICES INC.
- ARISGLOBAL
- BENCHLING
- BOX
- CISCO SYSTEMS INC.
- COGNIZANT
- DNANEXUS INC.
- IBM CORP.
- INFORMATICA INC.
- MICROSOFT
- ORACLE
- RESCALE INC.
- SALESFORCE INC.
- SAP SE
Product Code: BIO200B
List of Tables
- Summary Table : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 1 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
- Table 2 : Global Market for Human Biology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 3 : Global Market for Microbiology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 4 : Global Market for Animal Biology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 5 : Global Market for Plant Biology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 6 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
- Table 7 : Global Market for Public Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 8 : Global Market for Private Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 9 : Global Market for Hybrid Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 10 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
- Table 11 : Key Cloud Platform Software for Research Data Management and Analysis
- Table 12 : Global Market for Discovery and Preclinical Research Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 13 : Global Market for Clinical Trials Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 14 : Global Market for Pharma Manufacturing Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 15 : Global Market for Plant and Microbial Gene Analysis Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 16 : Global Market for Commercialization Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 17 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
- Table 18 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
- Table 19 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Clinical Laboratories, by Region, Through 2030
- Table 20 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Contract Research Organizations, by Region, Through 2030
- Table 21 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Other End Users, by Region, Through 2030
- Table 22 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
- Table 23 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, Through 2030
- Table 24 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
- Table 25 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
- Table 26 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
- Table 27 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
- Table 28 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, Through 2030
- Table 29 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
- Table 30 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
- Table 31 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
- Table 32 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
- Table 33 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, Through 2030
- Table 34 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
- Table 35 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
- Table 36 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
- Table 37 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
- Table 38 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
- Table 39 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
- Table 40 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
- Table 41 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
- Table 42 : Analysis of Patents on Cloud Computing in Cell Biology, Genomics and Drug Development Applications, January 2024-September 2025
- Table 43 : Global Ranking of Companies in the Cloud Computing Market for Cell Biology, Genomics and Drug Development, 2024
- Table 44 : Strategic Developments of Top Companies in Cloud Computing Market for Cell Biology, Genomics and Drug Development, 2025
- Table 45 : Information Sources for this Report
- Table 46 : Abbreviations Used in this Report
- Table 47 : Alphabet Inc. (Google Inc.): Company Snapshot
- Table 48 : Alphabet Inc. (Google Inc.): Financial Performance, FY 2023 and 2024
- Table 49 : Alphabet Inc. (Google Inc.): Product Portfolio
- Table 50 : Alphabet Inc. (Google Inc.): News/Key Developments, 2025
- Table 51 : Amazon Web Services Inc.: Company Snapshot
- Table 52 : Amazon Web Services Inc.: Financial Performance, FY 2023 and 2024
- Table 53 : Amazon Web Services Inc.: Product Portfolio
- Table 54 : Amazon Web Services Inc.: News/Key Developments, 2024 and 2025
- Table 55 : ArisGlobal: Company Snapshot
- Table 56 : ArisGlobal: Product Portfolio
- Table 57 : ArisGlobal: News/Key Developments, 2025
- Table 58 : Benchling: Company Snapshot
- Table 59 : Benchling: Product Portfolio
- Table 60 : Benchling: News/Key Developments, 2023-2025
- Table 61 : Box: Company Snapshot
- Table 62 : Box: Financial Performance, FY 2023 and 2024
- Table 63 : Box: Product Portfolio
- Table 64 : Box: News/Key Developments, 2024
- Table 65 : Cisco Systems Inc.: Company Snapshot
- Table 66 : Cisco Systems Inc.: Financial Performance, FY 2023 and 2024
- Table 67 : Cisco Systems Inc.: Product Portfolio
- Table 68 : Cisco Systems Inc.: News/Key Developments, 2024
- Table 69 : Cognizant: Company Snapshot
- Table 70 : Cognizant: Financial Performance, FY 2023 and 2024
- Table 71 : Cognizant: Product Portfolio
- Table 72 : Cognizant: News/Key Developments, 2024 and 2025
- Table 73 : DNAnexus Inc.: Company Snapshot
- Table 74 : DNAnexus Inc.: Product Portfolio
- Table 75 : DNAnexus Inc.: News/Key Developments, 2025
- Table 76 : IBM Corp.: Company Snapshot
- Table 77 : IBM Corp.: Financial Performance, FY 2023 and 2024
- Table 78 : IBM Corp.: Product Portfolio
- Table 79 : IBM Corp.: News/Key Developments, 2025
- Table 80 : Informatica Inc.: Company Snapshot
- Table 81 : Informatica Inc.: Financial Performance, FY 2023 and 2024
- Table 82 : Informatica Inc.: Product Portfolio
- Table 83 : Informatica Inc.: News/Key Developments, 2024 and 2025
- Table 84 : Microsoft: Company Snapshot
- Table 85 : Microsoft: Financial Performance, FY 2023 and 2024
- Table 86 : Microsoft: Product Portfolio
- Table 87 : Microsoft: News/Key Developments, 2024
- Table 88 : Oracle: Company Snapshot
- Table 89 : Oracle: Financial Performance, FY 2023 and 2024
- Table 90 : Oracle: Product Portfolio
- Table 91 : Oracle: News/Key Developments, 2024 and 2025
- Table 92 : Rescale Inc.: Company Snapshot
- Table 93 : Rescale Inc.: Product Portfolio
- Table 94 : Rescale Inc.: News/Key Developments, 2024 and 2025
- Table 95 : Salesforce Inc.: Company Snapshot
- Table 96 : Salesforce Inc.: Financial Performance, FY 2023 and 2024
- Table 97 : Salesforce Inc.: Product Portfolio
- Table 98 : Salesforce Inc.: News/Key Developments, 2025
- Table 99 : SAP SE: Company Snapshot
- Table 100 : SAP SE: Financial Performance, FY 2023 and 2024
- Table 101 : SAP SE: Product Portfolio
- Table 102 : SAP SE: News/Key Developments, 2024 and 2025
List of Figures
- Summary Figure : Global Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, 2024
- Figure 1 : Porter's Five Forces Analysis for the Cloud Computing in Cell Biology, Genomics and Drug Development Market
- Figure 2 : Snapshot of the Market Dynamics for Cloud Computing in Cell Biology, Genomics and Drug Development
- Figure 3 : Global Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, 2024
- Figure 4 : Global Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, 2024
- Figure 5 : Global Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, 2024
- Figure 6 : Global Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, 2024
- Figure 7 : Global Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, 2024
- Figure 8 : North American Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, 2024
- Figure 9 : European Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, 2024
- Figure 10 : Asia-Pacific Market Share for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, 2024
- Figure 11 : Alphabet Inc. (Google Inc.): Revenue Share, by Business Unit, FY 2024
- Figure 12 : Alphabet Inc. (Google Inc.): Revenue Share, by Country/Region, FY 2024
- Figure 13 : Cisco Systems Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 14 : Cisco Systems Inc.: Revenue Share, by Country/Region, FY 2024
- Figure 15 : Cognizant: Revenue Share, by Business Unit, FY 2024
- Figure 16 : Cognizant: Revenue Share, by Country/Region, FY 2024
- Figure 17 : IBM Corp.: Revenue Share, by Business Unit, FY 2024
- Figure 18 : IBM Corp.: Revenue Share, by Country/Region, FY 2024
- Figure 19 : Informatica Inc.: Revenue Share, by Country/Region, FY 2024
- Figure 20 : Microsoft: Revenue Share, by Business Unit, FY 2024
- Figure 21 : Microsoft: Revenue Share, by Country/Region, FY 2024
- Figure 22 : Oracle: Revenue Share, by Business Unit, FY 2024
- Figure 23 : Oracle: Revenue Share, by Country/Region, FY 2024
- Figure 24 : Salesforce Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 25 : Salesforce Inc.: Revenue Share, by Country/Region, FY 2024
- Figure 26 : SAP SE: Revenue Share, by Business Unit, FY 2024
- Figure 27 : SAP SE: Revenue Share, by Country/Region, FY 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.